EUVIMEDEUVIMED entdecken
Open Access

IL-4 alters TLR7-induced B cell developmental program in lupus

Changming Lu, Shanrun Liu, Min Gao, Jose Rubio, W Winn Chatham, Hui-Chen Hsu, John D Mountz

Clinical Immunology · 2025

DOI: 10.1016/j.clim.2025.110472 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Immunology, 2025. Verfasst von Changming Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA. Hauptthemen laut MEDLINE: Toll-Like Receptor 7, Lupus Erythematosus, Systemic, B-Lymphocytes, Interleukin-4. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH HHS, BLRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TLR7 stimulation of T-bet+CD11c+IgD-CD27- double-negative 2 (DN2) B cells is crucial for autoantibody formation in systemic lupus erythematosus (SLE). Here, we show that administration of IL-4 for five weeks significantly reduced autoantibodies and T-bet+CD11c+ IgD- B cells in autoimmune BXD2 mice treated with R848, a TLR7 agonist. Single-cell transcriptomics analysis indicates that following two doses of in vivo administration, IL-4 redirected development toward follicular, CD23+ germinal center (GC), and DN4-like memory B cells compared to treatment with R848 alone. While IL-4 enhanced genes related to antigen processing and presentation, it also suppressed R848-induced Ki67+ GC B cells in vivo. In vitro stimulation of SLE patient B cells with a DN2 polarizing cocktail revealed that IL-4 reduced the expression of interferon response and DN2 signature genes, promoting a population of CD23+T-bet- DN4 B population. These findings suggest that developmental reprogramming by IL-4 counteracts TLR7-promoted DN2 and GC B cells in SLE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 7Lupus Erythematosus, SystemicB-LymphocytesInterleukin-4AnimalsMiceHumansFemaleGerminal CenterImidazolesAutoantibodiesMembrane Glycoproteins

Stichwörter der Autor:innen

B cell(2)IL-4(3)TLR7(4)autoantibodies(6)lupus(1)transcriptomics(5)

Substanzen

Toll-Like Receptor 7Interleukin-4resiquimodTlr7 protein, mouseTLR7 protein, humanImidazolesAutoantibodiesMembrane Glycoproteins

Autor:innen und Institutionen

  • Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Clinical Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Department of Internal Medicine, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, Las Vegas, NV 89154, USA.
  • Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA; Medicine Service, Birmingham Veterans Affairs Health Care System, Birmingham, AL,…

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • BLRD VA
  • NIAMS NIH HHS
  • National Institutes of Health National Institute of Allergy and Infectious Diseases
  • National Institutes of Health
  • Lupus Research Alliance
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases

Zitieren

APA

Lu, C., Liu, S., Gao, M., Rubio, J., Chatham, W. W., Hsu, H. C., & Mountz, J. D. (2025). IL-4 alters TLR7-induced B cell developmental program in lupus. Clinical Immunology. https://doi.org/10.1016/j.clim.2025.110472

Vancouver

Lu C, Liu S, Gao M, Rubio J, Chatham WW, Hsu HC, et al. IL-4 alters TLR7-induced B cell developmental program in lupus. Clinical Immunology. 2025. doi:10.1016/j.clim.2025.110472

BibTeX
@article{Lu2025,
  author = {Lu, Changming and Liu, Shanrun and Gao, Min and Rubio, Jose and Chatham, W Winn and Hsu, Hui-Chen and Mountz, John D},
  title = {IL-4 alters TLR7-induced B cell developmental program in lupus},
  journal = {Clinical Immunology},
  year = {2025},
  doi = {10.1016/j.clim.2025.110472}
}
Kostenlos starten →